Patient no. | Sex | Age | Treatment months | Max. i.v. dose ng·kg·min−1 | Haemodynamics before i.v. iloprost# | NYHA class | 6‐min walk m | Outcome |
|
|
|
p.i.
|
i.v.
| RA | PAP | CI | PVR |
S
v,O2
|
p.i.
|
i.v.
|
p.i.
|
i.v.
|
|
1 | F | 33 | 4 | 3 | 2.2 | 23 | 64 | 0.9 | 2897 | 45 | 4 | 4 | 0 | 0# | Dead |
2 | F | 35 | 23 | 16 | 1.8 | 9 | 71 | 1.6 | 2066 | 57 | 3 | 4 | 250 | 180# | Dead |
3 | M | 63 | 17 | 7 | 1.6 | 14 | 59 | 1.6 | 1680 | 54 | 4 | 4 | 0 | 0# | Dead |
4 | F | 34 | 9 | 3 | 2.3 | 7 | 78 | 1.6 | 1875 | 60 | 4 | 4 | 150 | 100# | Dead |
5 | F | 26 | 19 | 3 | 2.5 | 9 | 66 | 1.6 | 1933 | 49 | 3 | 4 | 350 | 200# | Dead |
6 | F | 36 | 3 | 14 | 1.7 | 12 | 54 | 1.6 | 1469 | 46 | 3 | 3 | 280 | 200# | LT |
7 | F | 46 | 33 | 11 | 1.5 | 18 | 61 | 1.8 | 1537 | 48 | 4 | 3 | 268 | 388 | Alive |
8 | F | 66 | 23 | 10 | 1.8 | 8 | 52 | 1.3 | 1893 | 49 | 4 | 3 | 202 | 331 | Alive |
9 | F | 63 | 7 | 10 | 2.2 | 24 | 57 | 1.5 | 1537 | 53 | 4 | 3 | 192 | 387 | Alive |
10 | F | 34 | 12 | 3 | 1.5 | 9 | 61 | 1.3 | 1918 | 53 | 4 | 3 | 295 | 330# | LT |
11 | F | 50 | 5 | 3 | 1.8 | 11 | 50 | 2.0 | 1074 | 40 | 4 | 3 | 225 | 337# | LT |
12 | F | 30 | 3 | 11 | 2.4 | 9 | 74 | 1.4 | 2131 | 52 | 4 | 3 | 264 | 367 | Alive |
13 | F | 42 | 17 | 7 | 3.2 | 6 | 58 | 1.5 | 1732 | 52 | 4 | 3 | 145 | 297 | Alive |
14 | F | 61 | 27 | 9 | 1.6 | 9 | 69 | 1.6 | 1474 | 56 | 4 | 4 | 0 | 0 | Alive |
15 | F | 61 | 1 | 9 | 1.8 | 5 | 41 | 1.5 | 1299 | 56 | 4 | 3 | 243 | 316 | Alive |
16 | F | 39 | 1 | 7 | 2.1 | 16 | 65 | 1.7 | 1366 | 60 | 4 | 3 | 0 | 198 | Alive |
Mean | | 45 | 13 | 8 | 2.0 | 12 | 61 | 1.6 | 1742 | 52 | | | 179 | 227 | |
sd | | 14 | 10 | 4 | 0.4 | 6 | 9 | 0.2 | 425 | 6 | | | 118 | 140 | |